127696-07-5

Upstream product

• 127696-06-4 (2S-trans)-2,3-bis[(t-butyldiphenylsilyloxy)methyl]-cyclobutanone 
• 138736-92-2 (2S,3R)-(+)-bis[hydroxymethyl]-1,1-dimethoxycyclobutane 
• 138736-91-1 (1S,2R)-3,3-Dimethoxy-cyclobutane-1,2-dicarboxylic acid bis-((1R,2S,5R)-2-isopropyl-5-methyl-cyclohexyl) ester 
• 127760-56-9 (1R,2S,3S)-2,3-Bis-(tert-butyl-diphenyl-silanyloxymethyl)-cyclobutanol 

Relevant academic research and scientific papers

CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS

The present invention is directed to compounds of the formulae I, II and III as shown below wherein all substituents are defined herein, as well as pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions in the treatment of various disorders.

Enantio- and Diastereo-selective Synthesis of Carbocyclic Oxetanocin Analogues

Carbocyclic oxetanocin-A (COXT-A) (2a) and -G (COTX-G) (2b) were synthesised enantio- and diastereo-selectively; these compounds exhibited potent antiviral activities.